Of special interest, however, is the paper by Emerson’s group in 2005 that describes a CD44(lo)CD62L(hi)CD8(+) T cell subset that generate and sustain GVHD with self-renewing capacity. This evidence concerns the gene CD8A and graft versus host disease.